Jorma Paavonen, MD

All articles by Jorma Paavonen, MD

HPV-16/18 vaccine is highly effective in preventing precancerous cervical lesions

Offers a concise, practical summary of the research findings reported in Paavonen J, Naud P, Salmerón J, et al; the HPV PATRICIA study group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301-314.

Next post in Features